Olmecar 10 Tablet

About Olmecar 10 Tablet

Olmecar 10 is a 10 mg tablet containing Olmesartan Medoxomil, made by Square Pharmaceuticals PLC. It belongs to a group of medicines called angiotensin-II receptor blockers and is used to treat high blood pressure.

There are 29 brands of Olmesartan Medoxomil listed in Bangladesh. The lowest listed price is Belsar 10 mg Tablet at ৳ 6.00 per unit.

What is Olmecar 10 Tablet?

Olmecar 10 is an angiotensin-II receptor blocker tablet used for high blood pressure. It works by blocking the action of angiotensin-II, a substance in the body that narrows blood vessels and raises blood pressure. By blocking this effect, the medicine helps blood vessels relax. It can be prescribed on its own or alongside other blood pressure medicines. The doctor decides the dose and how long you take it, and may adjust it over time. Follow the instructions given to you and do not change the dose yourself. Ask your doctor or pharmacist if you have questions about your treatment.

Uses of Olmecar 10

Olmecar 10 is used to treat hypertension, which means high blood pressure. It may be used alone or together with other medicines that lower blood pressure. High blood pressure often has no obvious symptoms, so the medicine is usually taken regularly as part of a wider plan that your doctor arranges. Do not stop or change the medicine without advice from your doctor or pharmacist.

How to use Olmecar 10

Olmecar 10 is a tablet that is swallowed. The doctor decides the dose, how often you take it and how long the course lasts. Do not change these instructions yourself. Food does not affect how the body absorbs this medicine. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than guessing. Keep the tablet stored in a cool, dry place below 30°C, away from light and moisture, and out of the reach of children.

Side effects of Olmecar 10

Some people may notice side effects such as back pain, headache, diarrhoea, bronchitis, flu-like symptoms, a sore throat, a runny nose, sinus problems, or changes seen in blood tests. Less common effects include chest pain, swelling of the legs and ankles, and joint pain. Tell your doctor if any effect bothers you or does not settle. Get medical help promptly if you feel very unwell, faint, or notice swelling or breathing problems, and ask your doctor about anything you are worried about.

Safety and precautions

Tell your doctor before starting Olmecar 10 if you are allergic to any of its ingredients, since it should not be used in that case. It should not be used during pregnancy; if pregnancy is detected, the medicine should be stopped as soon as possible, so contact your doctor straight away. Breastfeeding mothers should discuss with their doctor whether to stop nursing or stop the medicine. People with kidney problems, especially severe heart failure, need careful review by their doctor. Always tell your doctor about other medicines and health conditions before starting.

Frequently asked questions

What is Olmecar 10 used for and what kind of medicine is it?

Olmecar 10 is used to treat high blood pressure. It is an angiotensin-II receptor blocker, a type of medicine that helps blood vessels relax by blocking the action of angiotensin-II. It may be used alone or with other blood pressure medicines. Your doctor will decide what suits you.

What side effects should I watch for, and when should I call the doctor?

Watch for back pain, headache, diarrhoea, flu-like symptoms, sore throat, runny nose or sinus problems, and less often chest pain, leg swelling or joint pain. Call your doctor if these bother you or do not settle, or if you feel very unwell, faint, or have swelling or breathing problems.

How should Olmecar 10 be taken?

Swallow the tablet as your doctor instructs. The doctor decides the dose, how often you take it and how long the course lasts, so do not change these yourself. Food does not affect how the medicine is absorbed. Ask your doctor or pharmacist if you are unsure about anything or miss a dose.

Can I take Olmecar 10 during pregnancy or while breastfeeding?

It should not be used during pregnancy, and it should be stopped as soon as possible if pregnancy is detected, so contact your doctor straight away. If you are breastfeeding, discuss with your doctor whether to stop nursing or stop the medicine. Always tell your doctor about pregnancy, breastfeeding or other health conditions first.

Indications

Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Pharmacology

Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).

Dosage & Administration

Dosage must be individualized. The usual recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan may be increased to 40 mg. Doses above 40 mg do not appear to have a greater effect. Twice-daily dosing offers no advantage over the same total dose given once daily.

No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40 ml/min) or with moderate to marked hepatic dysfunction. For patients with possible depletion of intravascular volume (e.g. patients treated with diuretics, particularly those with impaired renal function), Olmesartan should be initiated under close medical supervision and consideration should be given to use of a lower starting dose. Olmesartan may be administered with or without food.

Interaction

With medicine: No significant drug interactions were reported in which Olmesartan was co-administered.
With food & others: Food does not affect the bioavailability of Olmesartan.

Contraindications

Olmesartan is contraindicated in patients who are hypersensitive to any component of this product.

Side Effects

Common: The most common side effects include Back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Rare: Chest pain, peripheral edema, arthritis.

Pregnancy & Lactation

Pregnancy: When pregnancy is detected, discontinue this product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.

Nursing Mothers: It is not known whether Olmesartan is excreted in human milk, but Olmesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan medoxomil.

Overdose Effects

Symptoms: There is no experience of overdose with Olmesartan. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.

Treatment: If intake is recent, gastric lavage or induction of emesis may be considered. Clinically significant hypotension due to an overdose of Olmesartan requires the active support of the cardiovascular system, including close monitoring of heart and lung function, the elevation of the extremities, and attention to circulating fluid volume and urine output.

Storage Conditions

Store in cool & dry place below 30ºC, protect from light & moisture. Keep out of the reach of children.

Alternative brands of Olmesartan Medoxomil

Other brands with the same generic name, cheapest first.

See all 29 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.